Methods| We analyzed individual and prescription-level data from the Medical Expenditure
Panel Survey (MEPS) to describe and compare trends in expenditure and price of
antihyperglycemic medications in the United States from 2002 through 2013. The MEPS
involves deidentified, publicly available data of a nationally representative household survey
of noninstitutionalized residents. 4 The in-person interview response rate ranged from
69.2% to 58.0%. We first described the prevalence of treated patients with diabetes, their …